Drug Approval | July 22, 2024
Rusan Pharma’s API plant in Ankleshwar receives USFDA GMP approval
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Dyslipidemia is a critical risk factor for cardiovascular diseases
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India
The composition of ORAAL is protected by a granted patent in India until November 2033
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Agreement provides customers in the majority of Europe* access to supply through Univar Solutions distribution network
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Plantasens Pro LM is 100% natural, readily biodegradable, COSMOS and Natrue certified
Subscribe To Our Newsletter & Stay Updated
